{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:43:09Z","timestamp":1794040989479,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","award":["3.2 - 1184811 - KEN -SKP"],"award-info":[{"award-number":["3.2 - 1184811 - KEN -SKP"]}],"id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA 2015 SF1001"],"award-info":[{"award-number":["TMA 2015 SF1001"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015-02977"],"award-info":[{"award-number":["2015-02977"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02688"],"award-info":[{"award-number":["2018-02688"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["ALF20130207"],"award-info":[{"award-number":["ALF20130207"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["ALF20150135"],"award-info":[{"award-number":["ALF20150135"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Strengthening malaria surveillance is a key intervention needed to reduce the global disease burden. Reliable serological markers of recent malaria exposure could improve current surveillance methods by allowing for accurate estimates of infection incidence from limited data. We studied the IgG antibody response to 111\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    proteins in 65 adult travellers followed longitudinally after a natural malaria infection in complete absence of re-exposure. We identified a combination of five serological markers that detect exposure within the previous three months with &gt;80% sensitivity and specificity. Using mathematical modelling, we examined the antibody kinetics and determined that responses informative of recent exposure display several distinct characteristics: rapid initial boosting and decay, less inter-individual variation in response kinetics, and minimal persistence over time. Such serological exposure markers could be incorporated into routine malaria surveillance to guide efforts for malaria control and elimination.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-27863-8","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T06:02:52Z","timestamp":1642399372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7267-0749","authenticated-orcid":false,"given":"Victor","family":"Yman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tuju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7472-4138","authenticated-orcid":false,"given":"Michael T.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gathoni","family":"Kamuyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Mwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Kibinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9017-2206","authenticated-orcid":false,"given":"Muhammad","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6138-690X","authenticated-orcid":false,"given":"Christopher","family":"Sundling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Sond\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Murungi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kiboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinter","family":"Kimathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Chege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chepsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patience","family":"Kiyuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Nyamako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7133-5375","authenticated-orcid":false,"given":"Faith H. A.","family":"Osier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"F\u00e4rnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"27863_CR1","doi-asserted-by":"publisher","first-page":"e1002456","DOI":"10.1371\/journal.pmed.1002456","volume":"14","author":"RN Rabinovich","year":"2017","unstructured":"Rabinovich, R. N. et al. malERA: An updated research agenda for malaria elimination and eradication. PLoS Med. 14, e1002456 (2017).","journal-title":"PLoS Med."},{"key":"27863_CR2","doi-asserted-by":"publisher","first-page":"e1000400","DOI":"10.1371\/journal.pmed.1000400","volume":"8","author":"The malERA Consultative Group on Monitoring Evaluation and Surveillance.","year":"2011","unstructured":"The malERA Consultative Group on Monitoring Evaluation and Surveillance. A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med. 8, e1000400 (2011).","journal-title":"PLoS Med."},{"key":"27863_CR3","unstructured":"World Health Organzation. Global Technical Strategy for Malaria 2016\u20132030 (World Health Organisation, 2015)."},{"key":"27863_CR4","doi-asserted-by":"publisher","first-page":"E2694","DOI":"10.1073\/pnas.1314933111","volume":"111","author":"RC Reiner","year":"2014","unstructured":"Reiner, R. C. et al. Time-varying, serotype-specific force of infection of dengue virus. Proc. Natl Acad. Sci. USA 111, E2694\u2013E2702 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27863_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-21","volume":"12","author":"MT Bretscher","year":"2013","unstructured":"Bretscher, M. T. et al. Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren. Malar. J. 12, 21 (2013).","journal-title":"Malar. J."},{"key":"27863_CR6","doi-asserted-by":"publisher","first-page":"e0003555","DOI":"10.1371\/journal.pntd.0003555","volume":"9","author":"DL Martin","year":"2015","unstructured":"Martin, D. L. et al. Serology for trachoma surveillance after cessation of mass drug administration. PLoS Negl. Trop. Dis. 9, e0003555 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"27863_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s13071-016-1623-1","volume":"9","author":"A Golden","year":"2016","unstructured":"Golden, A. et al. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasit. Vectors 9, 338 (2016).","journal-title":"Parasit. Vectors"},{"key":"27863_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-103","volume":"13","author":"KA Kusi","year":"2014","unstructured":"Kusi, K. A. et al. Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation. Malar. J. 13, 103 (2014).","journal-title":"Malar. J."},{"key":"27863_CR9","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.0408725102","volume":"102","author":"CJ Drakeley","year":"2005","unstructured":"Drakeley, C. J. et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl Acad. Sci. USA 102, 5108\u20135113 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27863_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-169","volume":"9","author":"J Cook","year":"2010","unstructured":"Cook, J. et al. Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar. J. 9, 169 (2010).","journal-title":"Malar. J."},{"key":"27863_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/infdis\/jiu225","volume":"210","author":"BN Ondigo","year":"2014","unstructured":"Ondigo, B. N. et al. Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J. Infect. Dis. 210, 1123\u20131132 (2014).","journal-title":"J. Infect. Dis."},{"key":"27863_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.161.1.347","volume":"161","author":"DR Cavanagh","year":"1998","unstructured":"Cavanagh, D. R. et al. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J. Immunol. 161, 347\u2013359 (1998).","journal-title":"J. Immunol."},{"key":"27863_CR13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.vaccine.2004.05.031","volume":"23","author":"SD Polley","year":"2004","unstructured":"Polley, S. D. et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23, 718\u2013728 (2004).","journal-title":"Vaccine"},{"key":"27863_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep19472","volume":"6","author":"V Yman","year":"2016","unstructured":"Yman, V. et al. Antibody acquisition models: a new tool for serological surveillance of malaria transmission intensity. Sci. Rep. 6, 19472 (2016).","journal-title":"Sci. Rep."},{"key":"27863_CR15","doi-asserted-by":"publisher","first-page":"e1004882","DOI":"10.1371\/journal.pcbi.1004882","volume":"12","author":"B Borremans","year":"2016","unstructured":"Borremans, B., Hens, N., Beutels, P., Leirs, H. & Reijniers, J. Estimating time of infection using prior serological and individual information can greatly improve incidence estimation of human and wildlife infections. PLOS Comput. Biol. 12, e1004882 (2016).","journal-title":"PLOS Comput. Biol."},{"key":"27863_CR16","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4269\/ajtmh.18-0303","volume":"99","author":"B Greenhouse","year":"2018","unstructured":"Greenhouse, B., Smith, D. L., Rodr\u00edguez-Barraquer, I., Mueller, I. & Drakeley, C. J. Taking sharper pictures of malaria with CAMERAs: combined antibodies to measure exposure recency assays. Am. J. Trop. Med. Hyg. 99, 1120\u20131127 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"27863_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.12688\/gatesopenres.12897.1","volume":"3","author":"B Greenhouse","year":"2019","unstructured":"Greenhouse, B. et al. Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination. Gates Open Res. 3, 131 (2019).","journal-title":"Gates Open Res."},{"key":"27863_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/infdis\/jiu219","volume":"210","author":"MT White","year":"2014","unstructured":"White, M. T. et al. Dynamics of the antibody response to Plasmodium falciparum infection in African children. J. Infect. Dis. 210, 1115\u20131122 (2014).","journal-title":"J. Infect. Dis."},{"key":"27863_CR19","doi-asserted-by":"crossref","unstructured":"Yman, V. et al. Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: Kinetics and longevity in absence of re-exposure. BMC Med. 17, 22 (2019).","DOI":"10.1186\/s12916-019-1255-3"},{"key":"27863_CR20","doi-asserted-by":"crossref","unstructured":"Kinyanjui, S. M., Conway, D. J., Lanar, D. E. & Marsh, K. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar. J. 6, 82 (2007).","DOI":"10.1186\/1475-2875-6-82"},{"key":"27863_CR21","doi-asserted-by":"publisher","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","volume":"112","author":"DA Helb","year":"2015","unstructured":"Helb, D. A. et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc. Natl Acad. Sci. 112, E4438\u2013E4447 (2015).","journal-title":"Proc. Natl Acad. Sci."},{"key":"27863_CR22","doi-asserted-by":"publisher","first-page":"e0179146","DOI":"10.1371\/journal.pone.0179146","volume":"12","author":"R Perraut","year":"2017","unstructured":"Perraut, R. et al. Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities. PLoS ONE 12, e0179146 (2017).","journal-title":"PLoS ONE"},{"key":"27863_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4269\/ajtmh.15-0037","volume":"93","author":"CL King","year":"2015","unstructured":"King, C. L. et al. Biosignatures of exposure\/transmission and immunity. Am. J. Trop. Med. Hyg. 93, 16\u201327 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"27863_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1074\/mcp.RA118.001256","volume":"19","author":"C Proietti","year":"2020","unstructured":"Proietti, C. et al. Immune signature against plasmodium falciparum antigens predicts clinical immunity in distinct malaria endemic communities. Mol. Cell. Proteom. 19, 101\u2013113 (2020).","journal-title":"Mol. Cell. Proteom."},{"key":"27863_CR25","unstructured":"Helb, D. Anti-malarial Antibody Responses & Applications for Assessing Malaria Exposure (UC Berkeley, 2015)."},{"key":"27863_CR26","doi-asserted-by":"crossref","unstructured":"Kobayashi, T. et al. Distinct antibody signatures associated with different malaria transmission intensities in Zambia and Zimbabwe. mSphere 4, e00061 (2019).","DOI":"10.1128\/mSphereDirect.00061-19"},{"key":"27863_CR27","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fimmu.2020.00928","volume":"11","author":"LL van den Hoogen","year":"2020","unstructured":"van den Hoogen, L. L. et al. Selection of antibody responses associated with Plasmodium falciparum infections in the context of malaria elimination. Front. Immunol. 11, 928 (2020).","journal-title":"Front. Immunol."},{"key":"27863_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41591-020-0841-4","volume":"26","author":"RJ Longley","year":"2020","unstructured":"Longley, R. J. et al. Development and validation of serological markers for detecting recent Plasmodium vivax infection. Nat. Med. 26, 741\u2013749 (2020).","journal-title":"Nat. Med."},{"key":"27863_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01724-5","volume":"18","author":"L Wu","year":"2020","unstructured":"Wu, L. et al. Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia. BMC Med. 18, 304 (2020).","journal-title":"BMC Med."},{"key":"27863_CR30","doi-asserted-by":"crossref","unstructured":"Wu, L. et al. Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration. BMC Med. 18, 331 (2020).","DOI":"10.1186\/s12916-020-01785-6"},{"key":"27863_CR31","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.3389\/fmicb.2018.03300","volume":"9","author":"LL van den Hoogen","year":"2018","unstructured":"van den Hoogen, L. L. et al. Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human Plasmodium falciparum Infections. Front. Microbiol. 9, 3300 (2018).","journal-title":"Front. Microbiol."},{"key":"27863_CR32","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1038\/nature16039","volume":"528","author":"L Wu","year":"2015","unstructured":"Wu, L. et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature 528, S86\u2013S93 (2015).","journal-title":"Nature"},{"key":"27863_CR33","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/mt.2012.223","volume":"20","author":"SH Sheehy","year":"2012","unstructured":"Sheehy, S. H. et al. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Mol. Ther. 20, 2355\u20132368 (2012).","journal-title":"Mol. Ther."},{"key":"27863_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/imm.12428","volume":"145","author":"KM Walker","year":"2015","unstructured":"Walker, K. M. et al. Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships. Immunology 145, 71\u201381 (2015).","journal-title":"Immunology"},{"key":"27863_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1017\/S0031182015000761","volume":"143","author":"A Scholzen","year":"2016","unstructured":"Scholzen, A. & Sauerwein, R. W. Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum. Parasitology 143, 224\u2013235 (2016).","journal-title":"Parasitology"},{"key":"27863_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ebiom.2017.10.003","volume":"25","author":"MV Homann","year":"2017","unstructured":"Homann, M. V. et al. Detection of malaria parasites after treatment in travelers: a 12-months longitudinal study and statistical modelling analysis. EBioMedicine 25, 66\u201372 (2017).","journal-title":"EBioMedicine"},{"key":"27863_CR37","doi-asserted-by":"publisher","first-page":"e12702","DOI":"10.1111\/acel.12702","volume":"17","author":"M Asghar","year":"2018","unstructured":"Asghar, M. et al. Cellular aging dynamics after acute malaria infection: A 12-month longitudinal study. Aging Cell 17, e12702 (2018).","journal-title":"Aging Cell"},{"key":"27863_CR38","doi-asserted-by":"crossref","unstructured":"Sundling, C. et al. B cell profiling in malaria reveals expansion and remodeling of CD11c+ B cell subsets. JCI Insight 4, e126492 (2019).","DOI":"10.1172\/jci.insight.126492"},{"key":"27863_CR39","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3389\/fimmu.2018.02866","volume":"9","author":"G Kamuyu","year":"2018","unstructured":"Kamuyu, G. et al. KILchip v1.0: a novel Plasmodium falciparum merozoite protein microarray to facilitate malaria vaccine candidate prioritization. Front. Immunol. 9, 2866 (2018).","journal-title":"Front. Immunol."},{"key":"27863_CR40","unstructured":"World Health Organization. Disease Surveillance for Malaria Elimination: an Operational Manual. (World Health Organization, 2012)."},{"key":"27863_CR41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1017\/S0950268811002160","volume":"140","author":"JA Drewe","year":"2012","unstructured":"Drewe, J. A., Hoinville, L. J., Cook, A. J. C., Floyd, T. & St\u00e4rk, K. D. C. Evaluation of animal and public health surveillance systems: a systematic review. Epidemiol. Infect. 140, 575\u2013590 (2012).","journal-title":"Epidemiol. Infect."},{"key":"27863_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-publhealth-031816-044348","volume":"38","author":"SL Groseclose","year":"2017","unstructured":"Groseclose, S. L. & Buckeridge, D. L. Public health surveillance systems: recent advances in their use and evaluation. Annu. Rev. Public Health 38, 57\u201379 (2017).","journal-title":"Annu. Rev. Public Health"},{"key":"27863_CR43","first-page":"1","volume":"50","author":"R German","year":"2001","unstructured":"German, R. et al. Updated guidelines for evaluating public health surveillance systems. MMWR Recomm. Rep. 50, 1\u201335 (2001).","journal-title":"MMWR Recomm. Rep."},{"key":"27863_CR44","doi-asserted-by":"publisher","unstructured":"Avdicova, M. et al. Data quality monitoring and surveillance system evaluation: A handbook of methods and applications. ECDC Technical Document 1\u201391. https:\/\/doi.org\/10.2900\/35329 (2014).","DOI":"10.2900\/35329"},{"key":"27863_CR45","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1128\/EC.00218-09","volume":"8","author":"L Hinds","year":"2009","unstructured":"Hinds, L., Green, J. L., Knuepfer, E., Grainger, M. & Holder, A. A. Novel putative glycosylphosphatidylinositol-anchored micronemal antigen of plasmodium falciparum that binds to erythrocytes. Eukaryot. Cell 8, 1869\u20131879 (2009).","journal-title":"Eukaryot. Cell"},{"key":"27863_CR46","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1128\/IAI.05412-11","volume":"79","author":"TU Arumugam","year":"2011","unstructured":"Arumugam, T. U. et al. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Infect. Immun. 79, 4523\u20134532 (2011).","journal-title":"Infect. Immun."},{"key":"27863_CR47","unstructured":"Kamuyu, G. Identifying merozoite targets of protective immunity against Plasmodium falciparum Malaria (The Open University\/KEMRI-Wellcome Trust Research Programme, Kenya, 2017)."},{"key":"27863_CR48","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nature08104","volume":"459","author":"TF de Koning-Ward","year":"2009","unstructured":"de Koning-Ward, T. F. et al. A newly discovered protein export machine in malaria parasites. Nature 459, 945\u2013949 (2009).","journal-title":"Nature"},{"key":"27863_CR49","doi-asserted-by":"publisher","first-page":"247ra102","DOI":"10.1126\/scitranslmed.3008705","volume":"6","author":"FH Osier","year":"2014","unstructured":"Osier, F. H. et al. New antigens for a multicomponent blood-stage malaria vaccine. Sci. Transl. Med. 6, 247ra102 (2014).","journal-title":"Sci. Transl. Med."},{"key":"27863_CR50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.1254417","volume":"344","author":"DK Raj","year":"2014","unstructured":"Raj, D. K. et al. Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Science 344, 871\u2013877 (2014).","journal-title":"Science"},{"key":"27863_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0166-6851(01)00265-1","volume":"114","author":"CG Black","year":"2001","unstructured":"Black, C. G., Wu, T., Wang, L., Hibbs, A. R. & Coppel, R. L. Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 114, 217\u2013226 (2001).","journal-title":"Mol. Biochem. Parasitol."},{"key":"27863_CR52","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1189\/jlb.5MA0716-294R","volume":"101","author":"FJ McCallum","year":"2016","unstructured":"McCallum, F. J. et al. Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance. J. Leukoc. Biol. 101, 913\u2013925 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"27863_CR53","doi-asserted-by":"crossref","unstructured":"Burel, J. G. et al. Dichotomous miR expression and immune responses following primary blood-stage malaria. JCI insight 2, e93434 (2017).","DOI":"10.1172\/jci.insight.93434"},{"key":"27863_CR54","doi-asserted-by":"publisher","first-page":"e0005888","DOI":"10.1371\/journal.pntd.0005888","volume":"11","author":"RJ Longley","year":"2017","unstructured":"Longley, R. J. et al. Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions. PLoS Negl. Trop. Dis. 11, e0005888 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"27863_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1473-3099(08)70069-0","volume":"8","author":"SI Hay","year":"2008","unstructured":"Hay, S. I., Smith, D. L. & Snow, R. W. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect. Dis. 8, 369\u2013378 (2008).","journal-title":"Lancet Infect. Dis."},{"key":"27863_CR56","doi-asserted-by":"crossref","unstructured":"World Health Organization. Management of Severe Malaria: A Practical Handbook. World Health Organization Vol. 1 (World Health Organization, 2012).","DOI":"10.7591\/cornell\/9780801450655.003.0001"},{"key":"27863_CR57","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1016\/j.vaccine.2013.06.042","volume":"31","author":"LM Murungi","year":"2013","unstructured":"Murungi, L. M. et al. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. Vaccine 31, 3936\u20133942 (2013).","journal-title":"Vaccine"},{"key":"27863_CR58","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1021\/pr900412k","volume":"8","author":"A Sboner","year":"2009","unstructured":"Sboner, A. et al. Robust-linear-model normalization to reduce technical variability in functional protein microarrays research articles. J. Proteome Res. 8, 5451\u20135464 (2009).","journal-title":"J. Proteome Res."},{"key":"27863_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-556","volume":"11","author":"M Sill","year":"2010","unstructured":"Sill, M., Schr\u00f6der, C., Hoheisel, J. D., Benner, A. & Zucknick, M. Assessment and optimisation of normalisation methods for dual-colour antibody microarrays. BMC Bioinform. 11, 556 (2010).","journal-title":"BMC Bioinform."},{"key":"27863_CR60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodol.) 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B (Methodol.)"},{"key":"27863_CR61","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1109\/LSP.2014.2337313","volume":"21","author":"X Sun","year":"2014","unstructured":"Sun, X. & Xu, W. Fast implementation of DeLong\u2019s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process. Lett. 21, 1389\u20131393 (2014).","journal-title":"IEEE Signal Process. Lett."},{"key":"27863_CR62","first-page":"589","volume":"8","author":"R Nilsson","year":"2007","unstructured":"Nilsson, R., Pe\u00f1a, J. M., Bj\u00f6rkegren, J. & Tegn\u00e9r, J. Consistent feature selection for pattern recognition in polynomial time. J. Mach. Learn. Res. 8, 589\u2013612 (2007).","journal-title":"J. Mach. Learn. Res."},{"key":"27863_CR63","doi-asserted-by":"crossref","unstructured":"Kursa, M. B., Rudnicki, W. R., Hastie, T., Tibshirani, R. & Friedman, J. Feature selection with the Boruta Package. J. Stat. Softw. 36, 1\u201313 (2010).","DOI":"10.18637\/jss.v036.i11"},{"key":"27863_CR64","doi-asserted-by":"crossref","unstructured":"Dubitzky, W., Granzow, M. & Berrar, D. Fundamentals of Data Mining in Genomics and Proteomics (Springer Science & Business Media, 2007).","DOI":"10.1007\/978-0-387-47509-7"},{"key":"27863_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(18)30674-1","volume":"19","author":"M White","year":"2019","unstructured":"White, M. et al. Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials. Lancet Infect. Dis. 19, 327\u2013336 (2019).","journal-title":"Lancet Infect. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27863-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27863-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27863-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T09:07:03Z","timestamp":1726477623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27863-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27863"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27863-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.14.20242768","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"22 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}